Asklepios BioPharma Launches New Biotech Actus Therapeutics Post author:Sam Post published:December 14, 2017 Post category:BioPharma Asklepios BioPharma is forming a new biotech portfolio company, Actus Therapeutics. Source: BioSpace You Might Also Like Clovis Expands Bay Area Footprint With Huge Lease in Oakland November 27, 2017 Biogen Appoints Vice President Of Government Affairs July 9, 2017 Superstar Investors Jump in on Celgene Spinout Celularity's $250M Funding Round February 15, 2018
